New Zealand markets closed

Genflow Biosciences plc (GENF.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.6299-0.1051 (-6.06%)
As of 08:33AM BST. Market open.
Full screen
Previous close1.7350
Bid1.6000 x N/A
Ask1.7000 x N/A
Day's range1.6000 - 1.6299
52-week range1.4250 - 5.7000
Avg. volume1,134,998
Market cap7.513M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Genflow Biosciences PLC Announces Company Update

    Successful first regulatory interaction with the Federal Agency for Medicines and Health Products (FAHMP) And Internal Debt Restructuring First regulatory agency interaction results in recommendation to commence Phase I/II Clinical Trial in NASH Patients LONDON, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (“Genflow” or “the Company”) (LSE:GENF) (OTCQB:GENFF), today announced the receipt of written comments from the Federal Agency for Medicines and Health Products (FAHMP) of Belgiu

  • GlobeNewswire

    Life Science Investor Forum Agenda Announced for June 22nd

    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: It is recommended that investors pre-register and run the online system check to exped

  • GlobeNewswire

    Genflow Bioscineces to Present at the Life Science Investors Forum June 22nd

    Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.comLONDON, June 20, 2023 (GLOBE NEWSWIRE) -- Genflow Biosciences (OTCQB:GENFF), a biotechnology company based in the UK, focused on longevity, today announced that Dr. Eric Leire, CEO, will present live at the Life Science Investors Forum, hosted by, on June 22nd , 2023. DATE: June 22nd ,2023TIME: 11:00amLINK: https:/